Summary
Updated Aug 31, 2026
Daniel Joseph Apel is Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR). 1 SEC Form 4 filing on record, dated 24 April 2026. Most recent open-market trade: sold $628K of ARWR on 24 April 2026. Lifetime open-market sales: $934K.
Recent Transactions
3Every recent SEC Form 4 transaction Daniel Joseph Apel has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Daniel Joseph Apel go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. 3 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel Joseph Apel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Richard Anzalone - $12.35M of ARWR open-market activity in the last 12 months
- James C. Hamilton - $2.92M of ARWR open-market activity in the last 12 months
- Michael S. Perry - $1.01M of ARWR open-market activity in the last 12 months
- Mauro Ferrari - $493K of ARWR open-market activity in the last 12 months
- Hongbo Lu - $228K of ARWR open-market activity in the last 12 months
- Adeoye Y. Olukotun - $174K of ARWR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Daniel Joseph Apel?
Daniel Joseph Apel is a corporate insider, tracked as Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Daniel Joseph Apel last file a Form 4?
The only primary Form 4 on record is dated 24 April 2026.
Has Daniel Joseph Apel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($934K) across all tracked filings.
Where can I see all of Daniel Joseph Apel's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Daniel Joseph Apel and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial